These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6975637)

  • 1. Urinary excretion of sialic acid-containing saccharides in systemic lupus erythematosus.
    Maury CP; Sjöblom C; Wegelius O
    Arthritis Rheum; 1981 Sep; 24(9):1137-41. PubMed ID: 6975637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary sialyloligosaccharide excretion as an indicator of disease activity in rheumatoid arthritis.
    Maury CP; Wegelius O
    Rheumatol Int; 1981; 1(1):7-10. PubMed ID: 7346964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased excretion of two sialic acid-containing trisaccharides in the urine of patients with rheumatoid arthritis.
    Maury P
    Eur J Clin Invest; 1978 Dec; 8(6):405-9. PubMed ID: 105913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus.
    Maury CP; Teppo AM; Wegelius O
    Ann Rheum Dis; 1982 Jun; 41(3):268-71. PubMed ID: 7092339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum sialic acid in rheumatoid arthritis and systemic lupus erythematosus].
    Ota T; Uemura A; Eto S; Suzuki H
    J UOEH; 1985 Dec; 7(4):401-7. PubMed ID: 3878988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of sialic acids from exogenously administered sialyllactose and mucin in mouse and rat.
    Nöhle U; Schauer R
    Hoppe Seylers Z Physiol Chem; 1984 Dec; 365(12):1457-67. PubMed ID: 6526381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of ratio of urinary N-acetylneuraminlactose to free sialic acid in some advanced cancer patients.
    Shimada I; Shoji M; Futatsuya R; Katoh T; Kominato Y; Sakamoto T; Fujikura T
    J Gastroenterol; 1995 Feb; 30(1):21-7. PubMed ID: 7719410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization and linkage analysis of metal-ligated sialic acid containing oligosaccharides.
    Leavell MD; Leary JA
    J Am Soc Mass Spectrom; 2001 May; 12(5):528-36. PubMed ID: 11349950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
    Amoura Z; Piette JC; Chabre H; Cacoub P; Papo T; Wechsler B; Bach JF; Koutouzov S
    Arthritis Rheum; 1997 Dec; 40(12):2217-25. PubMed ID: 9416860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine oligosaccharide pattern in patients with hyperprolactinaemia.
    Ekman B; Wahlberg J; Landberg E
    Glycoconj J; 2015 Nov; 32(8):635-41. PubMed ID: 26275984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus.
    Ozben T; Nacitarhan S; Tuncer N
    Ann Clin Biochem; 1995 May; 32 ( Pt 3)():303-6. PubMed ID: 7632035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
    Lim KL; Jones AC; Brown NS; Powell RJ
    Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.
    Christian N; Smikle MF; DeCeulaer K; Daniels L; Walravens MJ; Barton EN
    West Indian Med J; 2007 Mar; 56(2):130-3. PubMed ID: 17910142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of antinuclear antibodies.
    Meryhew NL; Messner RP; Tan EM
    J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus.
    Silvestris F; Searles RP; Bankhurst AD; Williams RC
    Clin Exp Immunol; 1985 May; 60(2):329-38. PubMed ID: 3874025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.